Novavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19. Unsurprisingly, NVAX stock plunged from highs of $320 in 2021 to recent lows of $3.5. However, with the company announcing a deal with Sanofi (NASDAQ:SNY), the stock skyrocketed by 280% last month. With the likelihood of the return of the meme stock frenzy, it’s a good time to look at biotech stocks to buy for returns that can replicate the performance of NVAX stock. Therefore, I am looking at speculative ideas ...

Both biotechs have been struggling for a while, but there might be some hope for them. The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to dominate this market were much less successful. That group includes Novavax (NVAX 6.71%) and Inovio Pharmaceuticals (INO 0.94%). The former did launch a coronavirus vaccine in the U.S., but the latter never got that far. Both have substantially lagged the market over the past ...

The vaccine maker's recovery story is looking brighter. Novavax (NVAX 0.81%) stock has both soared and plummeted at times in recent years. Investors initially bet on the biotech company to be a winner in the coronavirus vaccine race, sending the stock to a 2,700% gain back in 2020. But when Novavax fell behind on the road to commercialization, the shares declined -- and even the eventual regulatory approval and market entry of that vaccine didn't much help. In recent times, though, Novavax has taken steps t ...

Shares of Novavax (NVAX) rose 13.7% on May 20 after the activist investor Shah Capital Management decided to withdraw its proxy campaign to remove the company’s three board members. This withdrawal comes a week after Novavax signed a multi-billion-dollar deal with pharma giant Sanofi (SNY) , breathing new life into the former, which had been facing uncertainties in its business for a long time. This deal even allowed Novavax to do away with its previous concerns about its ability to continue as a ‘going con ...

The price-action in some speculative stocks in the recent past is signaling the possible return of the meme stock euphoria. Stocks like Novavax (NASDAQ:NVAX) doubled overnight, and the rally has even increased. It’s, therefore, a good time to make quick money by holding positions in some cheap speculative stocks. Since we are talking about speculative ideas, the risk (beta factor) is high. Even if there is a euphoria in meme stocks, I would limit portfolio exposure to 5% to 10% to these speculative bets. At ...

Welcomes Recent Announcement by Novavax of Licensing Agreement with Sanofi Stresses Significant Value Still Remains to Be Unlocked at Novavax Still Believes Novavax Would Benefit from Stockholder Representative on Board RALEIGH, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Shah Capital Management, Inc. (together with its affiliates, "Shah Capital," "we" or "our") collectively beneficially owns ~7.9% of the outstanding common stock of Novavax, Inc. (NASDAQ:NVAX) ("Novavax" or the "Company"), making it a top three ...

The biotech still hasn't lost momentum. Vaccine maker Novavax (NVAX -9.65%) isn't dead in the water after all. Though the past 18 months have been tough -- and management warned investors that the business might sink soon -- Novavax reported positive developments in its latest quarterly update that doubled its share price in just one day. The biotech has come a long way since its not-so-successful attempt at dominating the coronavirus vaccine market. But do more recent developments make Novavax's stock a bu ...

Can Novavax's stock continue soaring? Novavax (NVAX -9.65%) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the healthcare stock are up 200% since the start of May. Investors are feeling bullish on the stock once again as it has soared to a new 52-week high. What's behind this recent rally, and is it a reason to be optimistic about Novavax for the long haul? Deal with Sanofi sparks a turnaround On May 10, Novavax announced a co-exclusive l ...

CHINA - 2023/02/15: In this photo illustration, the American vaccine for Covid-19 development ... [+] company Novavax logo is seen displayed on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images The stock price of Novavax (NASDAQ: NVAX), a Covid-19 vaccine developer, trades at $13 per share, about 96% below its peak level of $320 seen in February 2021. NVAX stock ...

The meme stock season seems to be back. Novavax (NASDAQ:NVAX) has surged over 200% in the last month, with big gains coming in a few trading days. GameStop (NYSE:GME) stock has also skyrocketed more than 290% in the last month. These are just two examples and speak volumes about the ferocity of the rally. Of course, I would not look at these overbought ideas, but I would certainly consider some meme stocks to buy if there is a broad market correction. An important point to note is that GDP growth in the U.S ...